Fulgent Genetics Inc (FLGT)
16.95
-0.33
(-1.91%)
USD |
NASDAQ |
Nov 21, 16:00
17.99
+1.04
(+6.14%)
Pre-Market: 09:12
Fulgent Genetics Total Liabilities (Quarterly): 98.86M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 98.86M |
June 30, 2024 | 103.39M |
March 31, 2024 | 103.24M |
December 31, 2023 | 102.04M |
September 30, 2023 | 96.56M |
June 30, 2023 | 91.25M |
March 31, 2023 | 107.85M |
December 31, 2022 | 116.18M |
September 30, 2022 | 124.38M |
June 30, 2022 | 150.93M |
March 31, 2022 | 152.63M |
December 31, 2021 | 112.84M |
September 30, 2021 | 160.22M |
June 30, 2021 | 129.13M |
March 31, 2021 | 197.52M |
December 31, 2020 | 131.07M |
September 30, 2020 | 60.36M |
June 30, 2020 | 8.872M |
Date | Value |
---|---|
March 31, 2020 | 7.953M |
December 31, 2019 | 5.979M |
September 30, 2019 | 6.619M |
June 30, 2019 | 5.294M |
March 31, 2019 | 5.691M |
December 31, 2018 | 2.752M |
September 30, 2018 | 2.266M |
June 30, 2018 | 2.987M |
March 31, 2018 | 2.415M |
December 31, 2017 | 3.006M |
September 30, 2017 | 3.399M |
June 30, 2017 | 3.072M |
March 31, 2017 | 3.524M |
December 31, 2016 | 3.561M |
September 30, 2016 | 5.513M |
June 30, 2016 | 5.075M |
December 31, 2015 | 0.686M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.979M
Minimum
Dec 2019
197.52M
Maximum
Mar 2021
103.06M
Average
105.62M
Median
Total Liabilities (Quarterly) Benchmarks
Delcath Systems Inc | 23.11M |
Star Equity Holdings Inc | 27.35M |
Exact Sciences Corp | 3.538B |
CytoSorbents Corp | 34.80M |
Progyny Inc | 225.10M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.234B |
Shareholders Equity (Quarterly) | 1.138B |
Debt to Equity Ratio | 0.0026 |
Current Ratio | 4.413 |
Net Debt Paydown Yield | 0.05% |